Research Watch: Semaglutide Associated With Lower Incidence of OSA in Post Hoc Analysis
Research Watch
The Shift Report by Sleep Pathways Guild
Research Watch | Sleep Review | June 26, 2026
Semaglutide Associated With Lower Incidence of OSA in Post Hoc Analysis
Here is the deal: A post hoc analysis of the SELECT trial suggests that semaglutide 2.4 mg is associated with a significantly lower incidence of obstructive sleep apnea in adults with overweight or obesity and established cardiovascular disease. While these findings are promising, Novo Nordisk notes that semaglutide is not currently approved to treat obstructive sleep apnea and further research is required.
Why sleep techs should care: This may affect how sleep professionals think about clinical practice, education, credentialing, patient safety, research, lab operations, career planning, or the future of the sleep field.
Best for: RPSGT, sleep educators, trainees, researchers, and curious night-shift readers
Worth your cafecito: Read the original source
Guild note: Sleep Pathways Guild is building study tools, career resources, and sleep-tech education support for the people who keep the lab lights on.
Calendar note: SLEEP 2026 is scheduled for Baltimore. The Shift Report will continue watching for official meeting updates.
RPSGT Exam Prep Resource
Preparing for the RPSGT exam or reviewing sleep technology basics? Try the Sleep Pathways Guild RPSGT exam prep web app. It is free to use and built for sleep technologist learners.
For more updates, visit SleepPathwaysGuild.com. Thank you for visiting The Shift Report today.
Important notice
AI-assisted listing notice: This listing was aided by automated tools and AI-assisted review. Information may be incomplete, outdated, or incorrect. Please verify details directly with the source organization before relying on it. To report corrections, updates, broken links, or concerns, contact Sleep Pathways Guild at [email protected].
The Shift Report is shared for education, career awareness, professional updates, and general information. It is not medical advice, mental health advice, legal advice, financial advice, billing advice, coding advice, employment advice, credentialing advice, or emergency guidance. Always consult the appropriate licensed professional, employer, payer, certifying body, accrediting organization, or official source for decisions affecting patient care, employment, billing, coding, credentialing, accreditation, or health.
Phone numbers, fax numbers, websites, job postings, accreditation status, board certification status, services offered, pay ranges, scholarships, CEC/CEU opportunities, and event details can change without notice. Accreditation, certification, job availability, pay, and eligibility should always be independently verified.